Obesity and cardiovascular disease: From pathophysiology to risk stratification

International Journal of Cardiology

Volumn 138, Issue 1, 2010, Pages 3-8

  Marinou, Kyriakoula ^a   Tousoulis, Dimitris ^a   Antonopoulos, Alexios S ^a   Stefanadi, Elli ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atherosclerosis; Cardiovascular disease; Diabetes; Endothelium; Inflammation; Obesity

Indexed keywords

ADINOPECTIN; ADIPOCYTOKINE; FATTY ACID; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN TYROSINE KINASE; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADIPOSE TISSUE; AGE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; DYSLIPIDEMIA; ENDOTHELIAL FUNCTION; FEMALE; GENDER; GLUTEAL OBESITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK; RISK STRATIFICATION; SMOKING; STRATIFICATION; VASCULAR ENDOTHELIUM; WAIST HIP RATIO;

CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETIC ANGIOPATHIES; HUMANS; INFLAMMATION; OBESITY; RISK ASSESSMENT; RISK FACTORS;

EID: 70749101115     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.135     Document Type: Review

References (69)

1. Kosti R.I., and Panagiotakos D.B. The epidemic of obesity in children and adolescents in the world. Cent Eur J Public Health 14 (2006) 151-159
2. Lazarou C., Panagiotakos D.B., Panayiotou G., and Matalas A.L. Overweight and obesity in preadolescent children and their parents in Cyprus: prevalence and associated socio-demographic factors-the CYKIDS study. Obes Rev (2008) May;9(3):185-93.
3. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
4. Haslam D.W., and James W.P. Obesity. Lancet 366 (2005) 1197-1209
5. Grundy S.M. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105 (2002) 2696-2698
6. Frayn K.N. Obesity and metabolic disease: is adipose tissue the culprit?. Proc Nutr Soc 64 (2005) 7-13
7. McGill Jr. H.C., McMahan C.A., Herderick E.E., et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105 (2002) 2712-2718
8. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2: 51S-209S.
9. Prospective Studies C. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) Mar 28;373(9669):1083-96.
10. Franzosi M.G. Should we continue to use BMI as a cardiovascular risk factor?. Lancet 368 (2006) 624-625
11. Sowers J.R. Obesity as a cardiovascular risk factor. Am J Med 115 Suppl 8A (2003) 37S-41S
12. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
13. Gurm H.S., Brennan D.M., Booth J., Tcheng J.E., Lincoff A.M., and Topol E.J. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 90 (2002) 42-45
14. de Koning L., Merchant A.T., Pogue J., and Anand S.S. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 28 (2007) 850-856
15. Lakka H.M., Lakka T.A., Tuomilehto J., and Salonen J.T. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 23 (2002) 706-713
16. Detection, evaluation, and treatment of high blood cholesterol in adults. Rev Panam Salud Publica 2001; 9: 338-44.
17. James W.P. Assessing obesity: are ethnic differences in body mass index and waist classification criteria justified?. Obes Rev 6 (2005) 179-181
18. Snyder E.E., Walts B., Perusse L., et al. The human obesity gene map: the 2003 update. Obes Res 12 (2004) 369-439
19. Dedoussis G.V., Kaliora A.C., and Panagiotakos D.B. Genes, diet and type 2 diabetes mellitus: a review. Rev Diabet Stud 4 (2007) 13-24
20. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
21. Cauchi S., Stutzmann F., Cavalcanti-Proenca C., et al. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J Mol Med (2009) Mar 3 [Electronic publication ahead of print].
22. Scuteri A., Sanna S., Chen W.M., et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3 (2007) e115
23. Pomp D., and Mohlke K.L. Obesity genes: so close and yet so far. J Biol 7 (2008) 36
24. Brochu M., Starling R.D., Tchernof A., Matthews D.E., Garcia-Rubi E., and Poehlman E.T. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 85 (2000) 2378-2384
25. McFarlane S.I., Banerji M., and Sowers J.R. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86 (2001) 713-718
26. Rimm E.B., Stampfer M.J., Giovannucci E., et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 141 (1995) 1117-1127
27. Assimacopoulos-Jeannet F. Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type 2 diabetes. Int J Obes Relat Metab Disord 28 Suppl 4 (2004) S53-S57
28. Ryo M., Nakamura T., Kihara S., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 68 (2004) 975-981
29. Caro J.F., Sinha M.K., Raju S.M., et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79 (1987) 1330-1337
30. Olefsky J.M. The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes 25 (1976) 1154-1162
31. [30 P, 2001 #281]. Abate N. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes its Complicat 14 (2000) 154-174
32. Frayn K.N. Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad. Med Princ Pract 11 Suppl 2 (2002) 31-40
33. Frayn K.N. Visceral fat and insulin resistance-causative or correlative?. Br J Nutr 83 Suppl 1 (2000) S71-S77
34. Sims E.A., Danforth Jr. E., Horton E.S., Bray G.A., Glennon J.A., and Salans L.B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29 (1973) 457-496
35. Wannamethee S.G., and Shaper A.G. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22 (1999) 1266-1272
36. Abate N., Garg A., Peshock R.M., Stray-Gundersen J., Adams-Huet B., and Grundy S.M. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 45 (1996) 1684-1693
37. Montague C.T., and O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49 (2000) 883-888
38. Chrysohoou C., Panagiotakos D.B., Pitsavos C., et al. The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study. Nutr Metab Cardiovasc Dis 17 (2007) 590-597
39. Tousoulis D., Antoniades C., and Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart 93 (2007) 1001-1007
40. Lyon C.J., Law R.E., and Hsueh W.A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
41. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., and Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 (1998) 897-901
42. Shek E.W., Brands M.W., and Hall J.E. Chronic leptin infusion increases arterial pressure. Hypertension 31 (1998) 409-414
43. Correia M.L., Morgan D.A., Mitchell J.L., Sivitz W.I., Mark A.L., and Haynes W.G. Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension 38 (2001) 384-388
44. Amasyali B., Kose S., Kursaklioglu H., Kilic A., and Isik E. Leptin in acute coronary syndromes: has the time come for its use in risk stratification?. Int J Cardiol (2008) Nov 12;130(2):264-5.
45. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
46. Vinik A.I. The metabolic basis of atherogenic dyslipidemia. Clin Cornerstone 7 (2005) 27-35
47. Bamba V., and Rader D.J. Obesity and atherogenic dyslipidemia. Gastroenterology 132 (2007) 2181-2190
48. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
49. Davos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003) 29-35
50. Vasan R.S. Cardiac function and obesity. Heart 89 (2003) 1127-1129
51. Rea T.D., Heckbert S.R., Kaplan R.C., et al. Body mass index and the risk of recurrent coronary events following acute myocardial infarction. Am J Cardiol 88 (2001) 467-472
52. Balsaver A.M., Morales A.R., and Whitehouse F.W. Fat infiltration of myocardium as a cause of cardiac conduction defect. Am J Cardiol 19 (1967) 261-265
53. Rabkin S.W. Epicardial fat: properties, function and relationship to obesity. Obes Rev 8 (2007) 253-261
54. Wee C.C., Mukamal K.J., Huang A., Davis R.B., McCarthy E.P., and Mittleman M.A. Obesity and C-reactive protein levels among white, black, and Hispanic US adults. Obesity 16 (2008) 875-880 [Silver Spring]
55. Keaney Jr. J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
56. Pasimeni G., Ribaudo M.C., Capoccia D., et al. Non-invasive evaluation of endothelial dysfunction in uncomplicated obesity: relationship with insulin resistance. Microvasc Res 71 (2006) 115-120
57. Vigili de Kreutzenberg S., Kiwanuka E., Tiengo A., and Avogaro A. Visceral obesity is characterized by impaired nitric oxide-independent vasodilation. Eur Heart J 24 (2003) 1210-1215
58. Antoniades C., Shirodaria C., Leeson P., et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J (2009) Mar 18 [Electronic publication ahead of print].
59. Antoniades C., Antonopoulos A.S., Bendall J.K., and Channon K.M. Targeting redox signaling in the vascular wall: from basic science to clinical practice. Curr Pharm Des 15 (2009) 329-342
60. Boden G., and Song W.W. Effects of insulin and free fatty acids on matrix metalloproteinases. Curr Diab Rep 8 (2008) 239-242
61. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
62. Lee K., Song Y.M., and Sung J. Which obesity indicators are better predictors of metabolic risk? Healthy twin study. Obesity 16 (2008) 834-840 [Silver Spring]
63. Balkau B., Deanfield J.E., Despres J.P., et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116 (2007) 1942-1951
64. Ingelsson E., Sullivan L.M., Fox C.S., et al. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation 116 (2007) 375-384
65. Liu K.H., Chan Y.L., Chan J.C., and Chan W.B. Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Atherosclerosis 179 (2005) 299-304
66. Liu K.H., Chan Y.L., Chan W.B., Kong W.L., Kong M.O., and Chan J.C. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes Relat Metab Disord 27 (2003) 1267-1273
67. Welch V., and Tang S.S. Treatment and control of BP and lipids in patients with hypertension and additional risk factors. Am J Cardiovasc Drugs 7 (2007) 381-389
68. Qaseem A., Vijan S., Snow V., Cross J.T., Weiss K.B., and Owens D.K. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 147 (2007) 417-422
69. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150